Immediate Impact

1 from Science/Nature 54 standout
Sub-graph 1 of 24

Citing Papers

Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies
2025 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
4 intermediate papers

Works of Kenichiro Matsuda being referenced

MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 Axis
2011
Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self-Renewal and Tumorigenicity of Glioblastoma Stem-Like Cells
2010
and 2 more

Author Peers

Author Last Decade Papers Cites
Kenichiro Matsuda 237 49 428 187 33 676
Danmei Xu 192 38 378 191 23 818
Lisa Nonnenmacher 216 54 448 149 21 673
Sylwester Piaskowski 236 68 334 219 39 694
Aizhen Xiao 168 25 391 187 20 764
Wei‐Hsiu Liu 98 42 344 208 42 702
Greg Foltz 215 29 496 152 19 715
Yolanda Ruano 263 74 310 142 39 699
Keita Togashi 188 23 345 212 35 644
Chunyu Gu 180 32 403 159 31 615
Carlos Clara 265 89 338 155 37 600

All Works

Loading papers...

Rankless by CCL
2026